No abstract

No abstract

RESUMOA paralisia facial periférica ocorre devido acometimento do nervo facial, caracterizada pela paralisia dos músculos da face. Tem etiologia multifatorial e acomete principalmente a população entre a terceira e oitava décadas de vida. A recuperação pode ocorrer em semanas ou até quatro anos dependendo do tipo e grau da lesão, tratamento e individualidade do paciente. O estudo tem por objetivo analisar o perfil etiológico de pacientes atendidos pelo projeto "Reabilitação em Paralisia Facial Periférica". A metodologia constou de obtenção de dados pessoais, diagnósticos, queixa principal, além de exame físico e teste de condução nervosa na face destes pacientes, contando com a participação de 28 deles. Dos resultados obtidos, a maior incidência é feminina (79%) na faixa etária dos 30-40 anos, de causa idiopática (25 casos). Concluímos que a caracterização do perfil de pessoas com PFP é importante para se realizar uma melhor avaliação, intervenção e tratamento. Palavras-chave: Paralisia Facial; Etiologia; Reabilitação; Nervo Facial; Perfil Etiológico. ETIOLOGICAL PROFILE OF PATIENTS WITH PERIPHERAL FACIAL PARALYSIS IN A REHABILITATION PROGRAM ABSTRACTPeripheral facial paralysis occurs because of the facial nerve affection, characterized by paralysis of facial muscles. It has a multifactorial etiology and mostly affects the population between the third and eighth decades of life. Recovery may occur in weeks or up to four years depending on the type and degree of the lesion, treatment and the patient's individuality. The study aims to analyze the etiologic profile from patients cared by the project "Rehabilitation in Peripheral Facial Paralysis". The methodology consisted of obtaining personal data, diagnostics, chief complaint, besides physical examination and nerve conduction test in the face of these patients, with the participation of 28 of them. From the results, the highest incidence is female (79%) in the age group of 30-40 years, idiopathic (25 cases). We conclude that the characterization of the profile of people with PFP is important to carry out a better evaluation, intervention and treatment.

Background Patellofemoral pain (PFP) is a common knee disorder that causes persistent pain, lower self-reported function and quality of life. People with PFP also present with altered psychological factors, which are associated with higher levels of pain and dysfunction. Mindfulness-based interventions (MBI) generally consist of meditative practices developed to provide a holistic approach to chronic conditions. However, the effects of MBI on clinical and psychological outcomes for people with PFP remains understudied. Methods This assessor-blinded, parallel, two-arm randomized clinical trial aims to investigate the effects of adding an 8-week online MBI program to exercise therapy and patient education on clinical and psychological factors for people with PFP. We also aim to investigate whether psychological factors mediate changes in pain and function. Sixty-two participants with PFP will be recruited and randomized into one of two treatment groups (Mindfulness or Control group). Both groups will receive an 8-week intervention involving exercise therapy and education delivered through an online platform. The Mindfulness group will additionally receive a MBI component including formal and informal practices. Outcomes will be assessed online at baseline, intervention endpoint (follow-up 1) and 12 months after intervention completion (follow-up 2). Comparisons between groups will be performed at all time points with linear mixed models. A mediation analysis will be performed using a 3-variable framework. Discussion Exercise therapy and patient education are considered the “best management” options for PFP. However, unsatisfactory long-term prognosis remains an issue. It is known that people with PFP present with altered psychological factors, which should be considered during the evaluation and treatment of people with PFP. Adding a MBI to the current best treatment for PFP may improve short and long-term effects by addressing the underlying psychological factors. Trial registration Registro Brasileiro de Ensaios Clínicos (ReBEC) RBR-4yhbqwk, registered in April 6, 2021.